"Latest MS News: Vaccines, Migraines, and Eye-Tracking Tech"

A nationwide study in France involving over 100,000 people found no association between vaccination and the risk of hospitalization due to MS flare-ups, except for a small increased risk associated with the pneumococcal vaccine. People with MS are about twice as likely to have migraines compared to the general population, according to a review study. Eye Tracking Neurological Assessment (ETNA), an artificial intelligence application that tracks eye movements, is being developed to measure disease severity and cognitive status in people with MS, potentially allowing for remote self-testing and improved access to specialist care. ETNA has been granted breakthrough device designation by the FDA and is undergoing development and review for approval in the US.